# NuevaBio

NuevaBio is a Private Equity based in Palo Alto, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Palo Alto, United States
- **Region:** North America
- **Address:** Palo Alto, United States
- **Founded:** 2022
- **Assets under management:** Undisclosed
- **Website:** nuevabio.com
- **LinkedIn:** https://www.linkedin.com/company/nuevabio

## Regulatory record

- **Reports private funds:** No

## About

NuevaBio is an investment company based in Palo Alto, California. Founded in 2022, it invests in biotech sector companies. NuevaBio has made two investments, including OrsoBio in a Series B round on September 06, 2024.

## Sectors

- Biotech
- Life Sciences

## People

- Mani Subramanian — Founder
- Manoj Desai — Founder
- Gans Ganapati — Founder

## Questions

### Does NuevaBio participate in fund commitments or only direct deals?

The firm's investment vehicle structure is not disclosed. Based on its early-stage focus and small team profile, NuevaBio is expected to make direct equity investments into portfolio companies rather than acting as a fund-of-funds allocator.

### Which sectors does NuevaBio actively invest in?

NuevaBio invests in biotechnology and life sciences broadly, encompassing therapeutics, diagnostics, and medical devices. The firm has not published a list of excluded sub-sectors, though its seed-stage orientation naturally precludes service-based healthcare or late-stage commercial assets.

## Related profiles

- [Nueterra Capital](https://altss.com/profile/nueterra-capital-management)
- [Nuevo Asia](https://altss.com/profile/nuevo-asia)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/nuevabio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology